Hospital
ST Clair Memorial Hospital
ST Clair Memorial Hospital was paid $2.76M by Medicaid between Jan 2018 and Dec 2024, across 170 billing codes. Its largest line is 99284, emergency room visit (serious) — 28% of everything it billed.
33Billing provider infoST CLAIR MEMORIAL HOSPITAL
PITTSBURGH, PA 15243
PITTSBURGH, PA 15243
33aNPI1073587119assigned 02/15/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$2.76M
24GClaims128,262
24DCodes billed170
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#79 of 154
Median peer was paid$2.82M
This provider vs. median1.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 204 | $16K | |
| 2019 | 52 | $2K | |
| 2020 | 14,940 | $326K | |
| 2021 | 70,187 | $1.57M | |
| 2022 | 15,192 | $307K | |
| 2023 | 16,353 | $309K | |
| 2024incomplete | 11,334 | $231K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 28% | 7,461 | 7,236 | $772K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 16% | 6,210 | 6,067 | $435K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 7.7% | 1,598 | 1,515 | $214K |
| G0378 | Hospital observation service, per hour | 7.2% | 224 | 212 | $199K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.9% | 489 | 476 | $80K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 2.0% | 12,282 | 10,965 | $56K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.9% | 241 | 240 | $51K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.8% | 561 | 548 | $49K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1.4% | 498 | 488 | $40K |
| 80051 | 1.4% | 7,596 | 7,314 | $38K | |
| 82565 | 1.3% | 7,910 | 7,459 | $36K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 1.2% | 3,573 | 3,328 | $34K |
158 more codes
| 70450 | Computed tomography, head or brain; without contrast material | 1.1% | 617 | $31K |
| T1015 | A visit at a community health center or clinic (one all-in rate) | 1.1% | 858 | $29K |
| 84520 | 1.0% | 7,417 | $29K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 132 | $27K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 164 | $25K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 315 | $25K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,596 | $24K |
| 80076 | <1% | 2,961 | $21K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 527 | $19K |
| 82947 | <1% | 7,213 | $18K | |
| 80053 | Comprehensive metabolic panel | <1% | 1,883 | $16K |
| 0002A | <1% | 396 | $16K | |
| 0001A | <1% | 411 | $15K | |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 425 | $15K |
| 80050 | General health panel | <1% | 316 | $15K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 603 | $15K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 438 | $14K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 93 | $14K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 208 | $14K |
| 71250 | <1% | 202 | $13K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 374 | $11K |
| 80061 | Lipid panel | <1% | 919 | $11K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,614 | $11K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,784 | $11K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 41 | $11K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 36 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 2,747 | $11K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 238 | $10K |
| 76830 | Ultrasound, transvaginal | <1% | 234 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,547 | $10K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 165 | $9K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 664 | $9K |
| 84484 | <1% | 1,241 | $8K | |
| 83880 | <1% | 325 | $8K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 1,110 | $7K |
| 93975 | <1% | 125 | $7K | |
| 83690 | <1% | 1,730 | $7K | |
| 81001 | <1% | 2,777 | $7K | |
| 76801 | <1% | 169 | $7K | |
| 77066 | Tomosynthesis, mammo | <1% | 78 | $7K |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 314 | $7K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 141 | $6K |
| 83735 | <1% | 1,064 | $6K | |
| 93971 | <1% | 123 | $5K | |
| 85730 | <1% | 964 | $5K | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 26 | $5K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 1,050 | $5K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 143 | $5K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 148 | $4K |
| 82607 | <1% | 396 | $4K | |
| 85610 | <1% | 1,442 | $4K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 696 | $4K |
| 73610 | <1% | 200 | $4K | |
| 84439 | <1% | 528 | $4K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 34 | $4K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 14 | $4K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 87 | $3K |
| 84702 | <1% | 229 | $3K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 182 | $3K |
| 85379 | <1% | 342 | $3K | |
| 81025 | <1% | 844 | $3K | |
| 73562 | <1% | 187 | $3K | |
| 77065 | Tomosynthesis, mammo | <1% | 42 | $3K |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 56 | $3K |
| 82803 | <1% | 135 | $3K | |
| 83605 | <1% | 471 | $3K | |
| 76642 | <1% | 63 | $3K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 377 | $2K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | <1% | 30 | $2K |
| 73630 | <1% | 210 | $2K | |
| 85027 | <1% | 432 | $2K | |
| 72141 | <1% | 12 | $2K | |
| 82728 | <1% | 216 | $2K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 30 | $2K |
| 86850 | <1% | 333 | $2K | |
| 76536 | <1% | 41 | $2K | |
| 70496 | <1% | 13 | $2K | |
| 88342 | <1% | 245 | $2K | |
| 87186 | <1% | 297 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 598 | $2K |
| 70498 | <1% | 12 | $2K | |
| 83721 | <1% | 198 | $1K | |
| 72100 | <1% | 65 | $1K | |
| 84481 | <1% | 61 | $1K | |
| 73030 | <1% | 90 | $1K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 148 | $1K |
| 86803 | <1% | 86 | $1K | |
| 86901 | <1% | 360 | $1K | |
| 86900 | <1% | 362 | $1K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 4,728 | $1K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 334 | $1K |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | <1% | 31 | $1K |
| 82550 | <1% | 222 | $1K | |
| 87088 | <1% | 196 | $1K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 13 | $1K |
| 87040 | <1% | 109 | $1K | |
| 82746 | <1% | 125 | $1K | |
| 82043 | <1% | 140 | $1K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 144 | $991.10 |
| 96367 | <1% | 41 | $983.03 | |
| 93970 | <1% | 14 | $982.12 | |
| 59025 | Fetal non-stress test | <1% | 110 | $825.33 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 21 | $815.93 |
| 83550 | <1% | 182 | $768.46 | |
| 93017 | <1% | 31 | $762.63 | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 12 | $761.90 |
| 84132 | <1% | 187 | $760.74 | |
| 73620 | <1% | 87 | $756.23 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 32 | $754.41 |
| 0004A | <1% | 16 | $710.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 28 | $672.69 |
| 82330 | <1% | 163 | $662.73 | |
| 86140 | <1% | 265 | $633.94 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 28 | $629.63 |
| 84295 | <1% | 156 | $626.29 | |
| 82310 | <1% | 378 | $541.71 | |
| 82948 | <1% | 768 | $516.70 | |
| 85014 | <1% | 291 | $501.40 | |
| 73110 | <1% | 41 | $464.08 | |
| 85652 | <1% | 176 | $461.58 | |
| 87806 | <1% | 15 | $432.60 | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 13 | $424.08 |
| 82435 | <1% | 115 | $381.38 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 650 | $373.67 |
| 36591 | <1% | 75 | $358.50 | |
| 73130 | <1% | 29 | $349.07 | |
| 86038 | <1% | 26 | $347.25 | |
| 84153 | <1% | 14 | $335.84 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 49 | $328.81 |
| 85007 | <1% | 99 | $314.00 | |
| C9290 | Injection, bupivacaine liposome, 1 mg | <1% | 226 | $300.19 |
| 94060 | <1% | 26 | $290.27 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,659 | $260.70 |
| 86618 | <1% | 12 | $260.09 | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 12 | $243.56 |
| 87070 | <1% | 51 | $225.65 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,432 | $162.71 |
| 87205 | <1% | 55 | $161.79 | |
| 84100 | <1% | 27 | $159.56 | |
| 87077 | <1% | 29 | $144.17 | |
| 83615 | <1% | 29 | $133.03 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 68 | $112.64 |
| 96376 | <1% | 299 | $99.08 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 904 | $86.38 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 890 | $77.42 |
| 87147 | <1% | 25 | $69.45 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 64 | $69.06 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 99 | $43.72 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 17 | $29.53 |
| 97162 | <1% | 12 | $29.13 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 995 | $23.15 |
| 85018 | <1% | 14 | $17.92 | |
| J2704 | Injection, propofol, 10 mg | <1% | 2,512 | $16.56 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 89 | $13.89 |
| 88304 | 0% | 17 | $0.00 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 19 | $0.00 |
| 76000 | 0% | 12 | $0.00 | |
| J0689 | Injection, cefazolin sodium (baxter), not therapeutically equivalent to j0690, 500 mg | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLUTTRINGER, ERIC (VICE PRESIDENT OF FINANCE)
| Provider | Location | Paid |
|---|---|---|
| ST Clair Medical Services INC | Pittsburgh, PA | $41K |
| ST Clair Medical Services INC | Pittsburgh, PA | $27K |
| ST. Clair Medical Services, INC. | Bethel Park, PA | $15K |
| ST Clair Medical Services, INC. | Bethel Park, PA | $1K |
| ST Clair Medical Services, INC. | Pittsburgh, PA | $1K |
| ST. Clair Medical Services, INC. | Bethel Park, PA | $108.00 |
| ST. Clair Medical Services INC. | Pittsburgh, PA | $0.00 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.